Meeting the United Nations Sustainability Goals

Sorbus Biomedical’s Cell Cultivation System can contribute to the United Nations Sustainable Development Goal (SDG) of Quality Education (Goal 4) in several impactful ways:

1. Enhanced Learning and Research Opportunities:
   • Practical Training: by providing state-of-the-art cell cultivation systems, educational institutions can offer students hands-on experience with advanced biotechnological tools, better preparing them for careers in science and technology.
   • Research Integration: these systems enable students and researchers to engage in cutting-edge research, promoting a deeper understanding of cell biology, biotechnology, and related fields.
2. Access to High-Quality Educational Resources:
   • Modern Equipment: the availability of advanced cell cultivation systems in educational institutions ensures that students and educators have access to the latest technology, improving the quality of education especially in low income countries where access to modern/latest technologies is restricted due to high cost and infrastructure requirements.
   • Educational Partnerships: collaborations between Sorbus Biomedical and academic institutions can lead to the development of specialized training programs, workshops, and courses, enhancing the overall educational experience.
3. Promotion of STEM Education:
   • Inspiring Future Scientists: exposure to advanced biotechnological equipment can inspire students to pursue careers in STEM (Science, Technology, Engineering, and Mathematics) fields.
   • Innovative Learning: incorporating these systems into the curriculum can promote innovative learning methods, encouraging critical thinking and problem-solving skills among students.
4. Support for Research and Development:
   • Facilitating Research: by providing reliable and efficient cell cultivation systems, Sorbus Biomedical supports academic research, leading to scientific discoveries and advancements.
   • Interdisciplinary Projects: these systems can be used in various interdisciplinary research projects, fostering collaboration between different academic departments and enhancing the overall research environment.
5. Capacity Building and Skill Development:
   • Professional Training: Sorbus Biomedical’s systems can be used for professional development and training programs, equipping educators and researchers with the necessary skills to operate and maintain advanced biotechnological equipment.
   • Technical Expertise: training on these systems helps build technical expertise within educational institutions, contributing to a highly skilled workforce in the biotechnology sector.
6. Global Educational Collaboration:
   • International Programs: Sorbus Biomedical can collaborate with global educational initiatives to provide access to their technology in developing regions, supporting educational equality and bridging the technology gap. One of the key design features of Sorbus Biomedical system is its closed loop nature, as a result of that, it does not require high tech lab equipment and facilities in order to function. This reduces the burden of high cost and infrastructure bringing cutting edge technology to everyone.
   • Knowledge Sharing: through partnerships and collaborative programs, Sorbus Biomedical can facilitate knowledge sharing and transfer of technology to institutions worldwide.
7. Contribution to Quality Research Publications:
   • High-Quality Data: reliable and advanced cell cultivation systems ensure high-quality data generation, leading to robust research findings and publications.
   • Academic Reputation: access to such technology can enhance the reputation of educational institutions, attracting top talent and funding opportunities.
   Examples of Implementation:
   • University Laboratories: equipping university biology and biotechnology laboratories with Sorbus Biomedical’s cell cultivation systems for practical coursework and research projects.
   • STEM Outreach Programs: incorporating these systems into outreach programs aimed at high school students to spark interest in biotechnology.
   • Collaborative Research Centres: establishing research centres in partnership with Sorbus Biomedical to focus on advanced cell biology research and education.

Sorbus Biomedical’s Cell Cultivation System contributes to the United Nations Sustainable Development Goal (SDG) 8, which aims to promote sustained, inclusive, and sustainable economic growth, full and productive employment, and decent work for all, in several ways:

1. Innovation and Industrialization:
   • Advanced Technologies: by providing cutting-edge cell cultivation technologies, Sorbus Biomedical supports the advancement of biotechnology and pharmaceuticals. This promotes industrial innovation, a key driver of economic growth.
   • High-Value Products: the ability to efficiently produce high-value biopharmaceuticals, such as therapeutic proteins and vaccines, contributes to the growth of the biotechnology sector, which is an important component of modern economies.
2. Productivity and Economic Growth:
   • Increased Efficiency: automation and optimization of cell culture processes lead to higher productivity in research and biomanufacturing. This efficiency translates into cost savings and increased output, driving economic growth in the biotech and pharmaceutical industries.
   • Scalable Solutions: the scalability of Sorbus Biomedical’s systems allows companies to expand their operations smoothly from research to large-scale production, facilitating economic growth through enhanced production capabilities.
3. Employment and Skills Development:
   • Job Creation: the growth of the biotechnology sector spurred by advanced technologies like those provided by Sorbus Biomedical leads to the creation of high-quality jobs. These include roles in research and development, biomanufacturing, quality control, and regulatory affairs.
   • Skill Development: the use of sophisticated cell cultivation systems necessitates a skilled workforce, promoting education and training in biotechnology and related fields. This contributes to a more knowledgeable and capable workforce, aligned with the goal of decent work and economic growth.
4. Sustainable Practices:
   • Resource Efficiency: automated and optimized cell cultivation systems reduce waste and improve resource utilization, supporting more sustainable industrial practices. Efficient use of resources aligns with economic growth that is environmentally sustainable.
   • Reduction in Contamination and Failures: enhanced control and monitoring reduce the risk of contamination and batch failures, ensuring consistent product quality and reducing economic losses, thus contributing to more stable and sustainable economic growth.
5. Healthcare and Social Impact:
   • Access to Medicines: efficient production of biopharmaceuticals can lead to lower costs and improved access to essential medicines and therapies. This has a positive social impact by improving public health, which in turn supports economic productivity.
   • Tackling Health Challenges: innovations in cell cultivation can accelerate the development of treatments and vaccines for diseases, contributing to global health security and economic stability.
6. Global Partnerships and Economic Integration:
   • Collaborations and Partnerships: Sorbus Biomedical’s technologies enable partnerships between academic institutions, research organizations, and industrial entities worldwide. Such collaborations enhance knowledge transfer and economic integration, fostering global economic growth.
   • Supporting Developing Economies: by providing advanced cell cultivation technologies, Sorbus Biomedical can help developing countries build their biotechnological capabilities, contributing to their economic development and integration into the global economy.

Sorbus Biomedical’s Cell Cultivation System aligns with the United Nations Sustainable Development Goal (SDG) 9, which focuses on industry, innovation, and infrastructure, in several ways. Here’s how:

1. Industry Enhancement:
   Advanced Manufacturing Techniques:
   • Automation: by automating cell cultivation processes, Sorbus Biomedical enhances manufacturing efficiency and productivity in the biopharmaceutical and biotechnology industries. This leads to more efficient production of biopharmaceuticals, vaccines, and other biotech products.
   • Scalability: their systems support both small-scale laboratory research and large-scale industrial production, facilitating the growth of biomanufacturing capabilities and fostering industrial development.
2. Innovation:
   Cutting-Edge Technology:
   • State-of-the-Art Systems: Sorbus Biomedical leverages advanced technologies such as automated control systems, real-time monitoring, and 3D culture systems, driving innovation in cell culture techniques.
   • Research and Development: the systems support innovative research in various fields including drug development, regenerative medicine, and tissue engineering, enabling breakthroughs that can lead to new therapies and medical solutions.
   Data Integration:
   • Smart Integration: integration with laboratory information management systems (LIMS) and other software tools enhances data management, analysis, and reproducibility, fostering an innovative research environment.
   • AI and Machine Learning: potential incorporation of AI and machine learning for optimizing cell culture conditions and predictive analytics represents a frontier in biomedical innovation.
3. Infrastructure Development:
   Supporting Biotech Infrastructure:
   • Modern Facilities: by providing state-of-the-art cell cultivation equipment, Sorbus Biomedical contributes to the development of modern and efficient biotechnology infrastructure, crucial for advanced research and production facilities.
   • Capacity Building: the scalability of Sorbus systems allows for the establishment and expansion of biotechnological infrastructure in both developed and developing regions, promoting global industrial growth.
   Sustainable Practices:
   • Efficiency and Sustainability: automated and optimized systems reduce resource consumption and waste, supporting sustainable industrial practices and infrastructure development.
   • Reduced Contamination Risk: closed system designs minimize contamination risks, improving the reliability and safety of biotechnological processes.
4. Economic Growth and Job Creation:
   Boosting Economic Activities:
   • Biotech Industry Growth: the advancement of biotechnological capabilities spurs economic growth by creating new markets and expanding existing ones in the biotech sector.
   • Employment Opportunities: the development and deployment of advanced cell cultivation systems create high-skilled job opportunities in research, development, manufacturing, and maintenance.
5. Global Health Impact:
   Improving Healthcare Infrastructure:
   • Innovative Therapies: by facilitating the development of new and effective medical treatments, Sorbus Biomedical’s systems contribute to improving healthcare infrastructure and patient outcomes globally.
   • Access to Medicine: enhanced production capabilities for biopharmaceuticals and vaccines support global health initiatives, making essential medicines more accessible, especially in low-resource settings.

Sorbus Biomedical’s Cell Cultivation System can contribute to meeting the United Nations Sustainable Development Goal (SDG) of reduced inequalities (Goal 10) in several ways. This goal focuses on reducing inequality within and among countries by ensuring equal opportunity and reducing disparities in access to resources and services. Here’s how Sorbus Biomedical’s technology aligns with and supports this goal:

1. Improving Healthcare Accessibility:
   • Enhanced Research and Development: Sorbus Biomedical’s advanced cell cultivation systems enable faster and more efficient research in drug development, leading to the discovery of new treatments and therapies. This can make cutting-edge medical treatments more accessible and affordable, particularly in underserved regions.
   • Affordable Biopharmaceuticals: by increasing the efficiency and scalability of biopharmaceutical production, Sorbus systems help lower the costs of producing vital medications, making them more accessible to lower-income populations.
2. Supporting Global Health Initiatives:
   • Vaccine Production: efficient and scalable cell cultivation systems are crucial for the rapid production of vaccines. This is particularly important in addressing global health emergencies and ensuring that vaccines are available to all countries, including low- and middle-income ones.
   • Tackling Infectious Diseases: the ability to cultivate a wide range of cells supports research and development of treatments for infectious diseases that disproportionately affect poorer regions.
3. Promoting Inclusive Economic Growth:
   • Job Creation and Training: the biotechnology sector, supported by advanced systems like those from Sorbus Biomedical, can create high-skilled jobs and training opportunities in developing regions, contributing to economic growth and reducing inequalities.
   • Supporting Local Biotechnology Industries: by providing scalable and efficient cell cultivation technologies, Sorbus can help local biotech companies in developing countries become more competitive, fostering local industry and reducing dependence on foreign imports.
4. Encouraging Global Collaboration:
   • Research Collaboration: Sorbus Biomedical’s technologies can facilitate international research collaborations, sharing knowledge and resources to address global health challenges. This fosters an inclusive approach to scientific discovery and technological advancement.
   • Access to Cutting-Edge Technology: ensuring that advanced cell cultivation technologies are available to researchers and institutions in developing countries can help bridge the gap in scientific capabilities and innovations.
5. Ethical and Sustainable Practices:
   • Sustainable Production Methods: Sorbus Biomedical’s systems incorporate sustainable and more affordable practices that reduce environmental impact, aligning with broader goals of sustainable development which include reducing inequalities through improved living conditions.
   • Ethical Research Support: by supporting ethical research practices, including equitable access to experimental treatments and technologies, Sorbus helps ensure that advancements in biomedical sciences benefit all populations.
6. Addressing Health Disparities:
   • Personalized Medicine: advanced cell cultivation systems support the development of personalized medicine, which can address health disparities by providing tailored treatments to diverse populations, improving health outcomes across different demographic groups.
   • Chronic Disease Management: by enabling research into chronic diseases that disproportionately affect certain populations, Sorbus systems contribute to reducing health inequalities and improving quality of life for marginalized groups.

Sorbus Biomedical’s Cell Cultivation Systems contribute to the United Nations Sustainable Development Goal (SDG) 12, which focuses on responsible consumption and production, through several key strategies and technological innovations. Here’s a detailed breakdown of how these systems align with and support this goal:

1. Resource Efficiency
   Automation and Precision
   • Reduced Waste: automated systems minimize human error and ensure precise use of reagents and materials, reducing waste.
   • Optimized Resource Use: advanced monitoring and control systems allow for optimal use of energy, water, and other resources, enhancing overall efficiency.
2. Sustainable Practices
   Energy Efficiency
   • Energy-Efficient Equipment: the cultivation systems are designed to be energy-efficient, using advanced technologies to minimize power consumption while maintaining optimal cell culture conditions.
   • Renewable Energy Integration: where possible, these systems can be integrated with renewable energy sources to further reduce their carbon footprint.
   Minimizing Environmental Impact
   • Closed System Design: reduces the risk of contamination and subsequent need for resource-intensive decontamination processes.
   • Biodegradable and Recyclable Materials: use of materials that are biodegradable or recyclable in the construction of their systems and consumables, reducing environmental impact.
3. Innovation and Infrastructure
   Advanced Manufacturing Techniques
   • Smart Manufacturing: implementing smart manufacturing techniques that are both resource-efficient and environmentally friendly.
   • Sustainable Materials: using sustainable materials in the production of equipment and components.
4. Support for Sustainable Research and Development
   Pharmaceuticals and Biotechnology
   • Efficient Drug Development: by providing reliable and reproducible cell culture conditions, Sorbus systems aid in the efficient development of new pharmaceuticals, reducing the time and resources needed for R&D.
   • Regenerative Medicine: support for research in regenerative medicine, potentially reducing the need for more resource-intensive medical treatments.
5. Education and Awareness
   Training and Knowledge Sharing
   • Training Programs: offering training programs for users to maximize the efficient use of their systems, thereby promoting best practices in resource use and sustainability.
   • Collaboration with Institutions: partnering with academic and research institutions to foster innovation in sustainable cell culture practices.
6. Long-Term Viability
   Durability and Longevity
   • High-Quality Manufacturing: the systems are built to last, reducing the need for frequent replacements and the associated environmental impact of manufacturing new equipment.
   • Maintenance and Upgrades: providing ongoing support and the ability to upgrade existing systems to extend their usable life.
7. Waste Management
   Recycling and Disposal Programs
   • Take-Back Programs: offering take-back programs for old or used equipment to ensure proper recycling and disposal.
   • Waste Reduction Initiatives: implementing initiatives to reduce waste generated during the production and operation of their systems.

Sorbus Biomedical’s Cell Cultivation Systems contribute to the United Nations Sustainable Development Goal (SDG) 13: Climate Action, by promoting sustainability and reducing the environmental impact of biomedical research and production processes. Here’s how their technologies align with the goal of climate action:

1. Energy Efficiency:
   • Optimized Energy Use: Sorbus systems are designed to be energy efficient, reducing the overall energy consumption needed for cell cultivation processes. This includes advanced insulation, efficient heating and cooling mechanisms, and energy-efficient components.
   • Reduced Carbon Footprint: by using less energy and a fraction of compressed gases (e.g. Nitrogen, Carbon dioxide and Oxygen) compared to commercially available alternatives, these systems contribute to lower greenhouse gas emissions directly supporting climate action goals.
2. Sustainable Production Practices:
   • Minimized Waste: automated and optimized processes result in reduced wastage of resources such as media, reagents, and other consumables. This leads to a more sustainable use of materials and lower environmental impact.
   • Recyclable and Biodegradable Materials: the use of environmentally friendly materials in the construction and operation of the systems helps in reducing waste and promoting recycling.
3. Resource Optimization:
   • Efficient Water Usage: advanced cell cultivation systems often incorporate water-saving technologies, ensuring that water usage is minimized without compromising the quality of cell cultures.
   • Nutrient Efficiency: systems are designed to optimize the use of nutrients, ensuring that cells receive only what they need, thereby reducing excess and waste.
4. Support for Green Technologies:
   • Bio-based Products: Sorbus systems can be used in the production of bio-based products, such as biofuels and bioplastics, which are more sustainable alternatives to fossil-fuel-based products.
   • Sustainable Bioprocessing: the ability to efficiently cultivate cells is essential for the development and production of sustainable bioprocesses that can replace traditional, more polluting industrial processes.
5. Reduced Transportation Emissions:
   • Local Production: by enabling efficient and scalable cell cultivation, Sorbus systems support local production of biopharmaceuticals and other biologics, reducing the need for transportation and the associated carbon emissions.
   • Compact and Portable Design: Sorbus systems are designed to be compact and portable, reducing the logistical and environmental costs associated with transportation and installation.
6. Innovation in Renewable Energy Integration:
   • Renewable Energy Sources: Sorbus systems can be integrated with renewable energy sources such as solar or wind power, further reducing their carbon footprint.
   • Energy Storage Solutions: incorporating energy storage solutions to manage energy use more effectively and sustainably.
7. Sustainability Research and Development:
   • Green Research Initiatives: Sorbus Biomedical supports research initiatives focused on sustainability and environmental health, contributing to broader efforts to combat climate change.
   • Educational Programs: promoting awareness and education on sustainable practices within the biomedical field.
   Practical Examples:
   • Reducing Laboratory Waste: automated systems reduce the need for single-use plastics and other disposable materials commonly used in manual cell cultivation processes.
   • Supporting Renewable Resources: cultivating cells for renewable bioproducts such as plant-based alternatives to plastic or biofuels, which help reduce dependence on fossil fuels.

Sorbus Biomedical’s Cell Cultivation System may contribute to the UN goal of peace, justice, and strong institutions in several ways:

1. Health Advancements: by developing technologies for cell cultivation, Sorbus Biomedical can contribute to advancements in healthcare. Improved healthcare systems can lead to healthier populations, which are often more stable and less prone to conflict.
2. Access to Medical Innovations: making advancements in biomedical technology more accessible can contribute to achieving justice by ensuring that medical breakthroughs benefit all segments of society, not just the privileged few. This can help bridge inequalities in healthcare access and outcomes.
3. Ethical Practices: upholding ethical standards in biomedical research and application is crucial. Sorbus Biomedical can promote justice by ensuring that their technologies are developed and used in accordance with ethical guidelines, respecting human rights and fostering trust in institutions.
4. Institutional Strengthening: supporting research and development in biomedicine strengthens scientific institutions globally. This contributes to building strong, accountable institutions capable of addressing health challenges effectively, which is foundational for sustainable development and peace.
5. Global Collaboration: collaborating with international partners on biomedical research and technology transfer can promote peaceful relations among nations. Shared scientific achievements foster cooperation and understanding, which are essential for global peace and stability.

Sorbus Biomedical’s Cell Cultivation System can contribute to the UN goal of partnerships for the goals in several ways:

1. Collaboration with Research Institutions and Universities: Sorbus Biomedical can partner with research institutions and universities globally to advance cell cultivation technologies. These partnerships foster knowledge sharing, joint research initiatives, and the training of future scientists and engineers in biotechnology.
2. Joint Ventures with Biotechnology Companies: collaborating with other biotechnology companies allows Sorbus Biomedical to combine expertise and resources, accelerating the development and adoption of innovative cell cultivation systems. Such partnerships can also lead to the creation of new business models and commercialization strategies that benefit multiple stakeholders.
3. Engagement with Governments and NGOs: working with governments and non-governmental organizations (NGOs), Sorbus Biomedical can align its cell cultivation technologies with public health priorities, such as improving access to regenerative medicine or supporting sustainable agricultural practices. This collaboration can also involve policy advocacy and regulatory frameworks that promote ethical and safe deployment of biotechnologies.
4. Supporting Sustainable Development Goals (SDGs): the Cell Cultivation System can be designed and promoted in ways that contribute directly to specific SDGs, such as SDG 3 (Good Health and Well-being), SDG 9 (Industry, Innovation, and Infrastructure), and SDG 17 (Partnerships for the Goals). For example, improving access to affordable medical treatments (SDG 3) through scalable cell cultivation technologies or enhancing technological capabilities in developing countries (SDG 9) through partnerships with local stakeholders.
5. Sharing Best Practices and Standards: engaging in partnerships allows Sorbus Biomedical to share best practices, establish industry standards, and promote responsible business practices across the biotechnology sector. This can include initiatives for ethical sourcing, environmental sustainability, and transparency in research and development processes.